Skip to main content

Table 1 The number of children bearing oral HPV DNA and HPV antibodies at any visit during the FU

From: Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative

HPV genotype

Case group (n = 10)

Control group (n = 21)

Oral HPV DNA

HPV L1 antibodies

Oral HPV

HPV L1 antibodies

Any HPV type

5 (50 %)

9 (90 %)

12 (57 %)

16 (76 %)

HPV6

3

8

4

10

HPV11

0

0

1

7

HPV16

1

3

7

6

HPV18

2

2

2

8

HPV31

2

 

0

 

HPV33

1

0

HPV39

0

1

HPV45

0

0

1

HPV70

1

 

1

 
  1. Oral HPV was tested at birth, at the age of 3 days, 1, 2, 6, 12, 24, 36 and 72 months. Serum antibodies for HPV capsid protein L1 were tested at the age of 1, 2, 6, 12, 24, and 36 months